Molecule Group (MOL)

Sector:

Alternative Investment Instruments

 206.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 276.50
  • 52 Week Low: 191.00
  • Currency: UK Pounds
  • Shares Issued: 27.28m
  • Volume: 17,778
  • Market Cap: ｣56.19m
  • Beta: 0.00

Molecule Group Overview

Molecule Group plc is building a leading regulated UK ePharmacy through buy and build. Our strategy is to lead the consolidation of the private prescription sector of the regulated UK ePharmacy market, one of the fastest growing and most profitable sectors of the market.

Key Personnel

CEO: Michael Kraftman
CFO: Keith Butcher
COO: Brendan O達rien
Non-Executive Chairman: Susan Clement Davies
Non-Executive Dir: Martin James Glanfield, David Wong

Contact Details

Address: 201 Temple Chambers , 3-7 Temple Avenue ,London, United Kingdom, EC4Y 0DT
Phone: +44 0207 583 8304
Website: http://www.molecule-group.com/

Listings

Sector: Alternative Investment Instruments(LSE)
ISIN: GB00BTQLZH16

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Molecule Group Market Data

Currency UK Pounds
Share Price 206.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 276.50
52 Week Low 191.00
Volume 17,778
Shares Issued 27.28m
Market Cap ｣56.19m
Beta 0.00

Molecule Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.16% below the market average6.16% below the market average6.16% below the market average6.16% below the market average6.16% below the market average
20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average
Income Not Available
Growth Not Available

Molecule Group Dividends

No dividends found

Trades for 16-Oct-2026

Time Volume / Share Price
14:02 10,000 @ 209.00p
14:47 2,057 @ 203.75p
13:35 3,330 @ 202.00p
14:18 857 @ 210.00p
10:31 300 @ 203.60p

Molecule Group Key Personnel

CEO Michael Kraftman
COO Brendan O達rien
CFO Keith Butcher

Top of Page